Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(16 sites)
United States
Exelixis Clinical Site #12, Fountain Valley, California Exelixis Clinical Site #15, Jacksonville, Florida Exelixis Clinical Site #8, Orlando, Florida Exelixis Clinical Site #16, Tampa, Florida Exelixis Clinical Site #14, Rochester, Minnesota Exelixis Clinical Site #10, Kansas City, Missouri Exelixis Clinical Site #9, New Brunswick, New Jersey Exelixis Clinical Site #5, New York, New York Exelixis Clinical Site #7, Cleveland, Ohio Exelixis Clinical Site #13, Oklahoma City, Oklahoma Exelixis Clinical Site #11, Germantown, Tennessee Exelixis Clinical Site #6, Nashville, Tennessee Exelixis Clinical Site #4, Austin, Texas Exelixis Clinical Site #1, Houston, Texas Exelixis Clinical Site #2, Houston, Texas Exelixis Clinical Site #3, San Antonio, Texas